98 related articles for article (PubMed ID: 9652567)
1. Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system.
Toliat MR; Berger W; Ropers HH; Neuhaus P; Wiedenmann B
Lancet; 1997 Oct; 350(9086):1223. PubMed ID: 9652567
[No Abstract] [Full Text] [Related]
2. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
Komminoth P
Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
Guo SS; Wu AY; Sawicki MP
World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
[TBL] [Abstract][Full Text] [Related]
5. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours.
Farrell WE; Simpson DJ; Bicknell J; Magnay JL; Kyrodimou E; Thakker RV; Clayton RN
Br J Cancer; 1999 Apr; 80(1-2):44-50. PubMed ID: 10389976
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutation of the MEN1 gene in parathyroid tumours.
Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
[TBL] [Abstract][Full Text] [Related]
8. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
9. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
11. [Associated gastroenteropancreatic neuroendocrine tumours to familiar syndromes].
Lecumberri Pascual E
Endocrinol Nutr; 2009 Apr; 56 Suppl 2():10-5. PubMed ID: 19627764
[TBL] [Abstract][Full Text] [Related]
12. A long-sought needle in the haystack: the multiple endocrine neoplasia type 1 gene.
Kopp P
Eur J Endocrinol; 1997 Sep; 137(3):222-3. PubMed ID: 9330583
[No Abstract] [Full Text] [Related]
13. Circulating markers for endocrine tumours of the gastroenteropancreatic tract.
Ardill JE
Ann Clin Biochem; 2008 Nov; 45(Pt 6):539-59. PubMed ID: 18941127
[TBL] [Abstract][Full Text] [Related]
14. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland.
Kytölä S; Villablanca A; Ebeling T; Nord B; Larsson C; Höög A; Wong FK; Välimäki M; Vierimaa O; Teh BT; Salmela PI; Leisti J
J Med Genet; 2001 Mar; 38(3):185-9. PubMed ID: 11303512
[No Abstract] [Full Text] [Related]
15. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
[TBL] [Abstract][Full Text] [Related]
16. [Identification of the gene associated with type 1 multiple endocrine neoplasia (NEM 1) susceptibility: a new pathway in the pathogenesis of neuro-endocrine tumors].
Calender A
Bull Cancer; 1997 Oct; 84(10):993-5. PubMed ID: 9435804
[TBL] [Abstract][Full Text] [Related]
17. Hereditary neuroendocrine tumors of the gastroenteropancreatic system.
Anlauf M; Garbrecht N; Bauersfeld J; Schmitt A; Henopp T; Komminoth P; Heitz PU; Perren A; Klöppel G
Virchows Arch; 2007 Aug; 451 Suppl 1():S29-38. PubMed ID: 17684762
[TBL] [Abstract][Full Text] [Related]
18. Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1.
Sakurai A; Shirahama S; Fujimori M; Katai M; Itakura Y; Kobayashi S; Amano J; Fukushima Y; Hashizume K
J Hum Genet; 1998; 43(3):199-201. PubMed ID: 9747036
[TBL] [Abstract][Full Text] [Related]
19. A patient with multiple endocrine neoplasia type 1 with a novel MEN1 gene mutation (237delC).
Sakai Y; Masamune A; Asakura T; Shimosegawa T; Takeda K; Watanabe M; Suzuki T
J Gastroenterol; 2002; 37(6):485-7. PubMed ID: 12108687
[No Abstract] [Full Text] [Related]
20. Efficient mutation detection in MEN1 gene using a combination of single-strand conformation polymorphism (MDGA) and heteroduplex analysis.
Crépin M; Escande F; Pigny P; Buisine MP; Calender A; Porchet N; Odou MF;
Electrophoresis; 2003 Jan; 24(1-2):26-33. PubMed ID: 12652570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
